2nd Annual Oncology Clinical Development Congress, 14th & 15th October 2013, Manchester
This event provides informative discussions in optimising oncology clinical development and overcoming operational challenges of clinical trials. It is estimated that each year 12.7million people are diagnosed with cancer across the globe. Our experts will discuss the latest advances in the development of targeted therapies and explore their translation into clinical trials.
On day one hear from industry leaders working at the forefront of oncology co-development. Topics for discussion include identifying appropriate clinical endpoints, mechanisms of cancer drug resistance, strategies to reach critical go/no go decisions and novel imaging technologies.
On day two our distinguished speakers will explore case studies of global clinical trials, strategies to overcome operational challenges and methods to ensure effective patient recruitment and retention. Our experts will discuss approaches to reduce clinical timelines, cost of adaptive clinical trial designs and methods of appropriate site selection.
For more information please email firstname.lastname@example.org or visit http://www.oncologyclinicaldevelopment-congress.com/